Skip to main content

Animations

MJFF Publications

6451 - 6460 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2018
  • 2019
  • 2019
  • 2025
  • 2017
  • 2024
  • 2014
  • 2024
  • 2020
  • Summary Details
    RESTRICTED
    Title: A role for lysosomal calcium channels in mitigating mitochondrial damage and oxidative stress
    Journal Name: Cell Calcium
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ceca.2024.102986
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s Disease
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12035-018-1109-6
    Citation Count: 56
  • Summary Details
    OPEN
    Title: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Targeting the Dopaminergic System in Autoimmunity
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-019-09834-5
    Citation Count: 72
  • Summary Details
    OPEN
    Title: Relationships between neuropsychiatric symptoms, subtypes of astrocyte activities, and brain pathologies in Alzheimer's disease and Parkinson's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.70242
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1616874114
    Citation Count: 79
  • Summary Details
    RESTRICTED
    Title: Selection of DNA aptamers that prevent the fibrillization of α-synuclein protein in cellular and mouse models
    Journal Name: Molecular Therapy - Nucleic Acids
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.omtn.2024.102251
    Citation Count: 3
  • Summary Details
    RESTRICTED
    Title: What matters to people with Parkinson’s disease living in Australia?
    Journal Name: Journal of Clinical Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jocn.2014.06.097
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Correlation of Presynaptic and Postsynaptic Proteins with Pathology in Alzheimer’s Disease
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms25063130
    Citation Count: 5
  • Summary Details
    OPEN
    Title: A Comparative Photophysical Study of Structural Modifications of Thioflavin T-Inspired Fluorophores
    Journal Name: The Journal of Physical Chemistry Letters
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jpclett.0c01549
    Citation Count: 25
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.